Regulatory Strategy Development

Overview

Bringing a medical device to market requires more than technical excellence and quality manufacturing. It demands a clear, well-structured regulatory strategy that anticipates requirements, identifies potential obstacles, and positions your product for efficient approval in every target market. At Veritas Quality Solutions, we develop and implement customized regulatory roadmaps tailored to your device, your business objectives, and your global market priorities.

A well-designed regulatory strategy is not a one-time document. It is a living framework that evolves with your product, your markets, and the changing regulatory landscape. Our team works with you at every phase, from early concept and design through to market approval, launch, and post-market sustainability.

What is Regulatory Strategy Development?

Regulatory strategy development is the process of defining the most efficient and compliant pathway to bring your medical device to market in one or more jurisdictions. It involves:

Understanding your device: Its classification, intended use, technological characteristics, and risk profile

Identifying target markets: Where you intend to sell and what each market requires

Evaluating applicable regulations: The specific rules, standards, and guidance documents that apply

Determining the optimal approval pathway: The route that minimizes time, cost, and regulatory risk while ensuring full compliance

Sequencing market entries: Deciding which markets to prioritize and how approvals in one market can support approvals in others

Anticipating obstacles: Identifying potential issues before they become delays

The result is a roadmap that tells you what to do, when to do it, and what evidence you need to support each step.

Why Regulatory Strategy Matters

1. Accelerates Time to Market

A well-planned regulatory strategy eliminates wasted effort, reduces back-and-forth with regulators, and ensures that documentation is complete and correct the first time. Manufacturers who plan strategically typically achieve approvals faster than those who approach each market in isolation.

2. Avoids Costly Delays

Incomplete submissions, incorrect classification, or missed requirements can result in lengthy review delays, requests for additional information, or even rejection. A robust strategy identifies and addresses these issues before submission.

3. Ensures Global Consistency

A device approved in one market may not automatically qualify for approval in another. A strategic approach ensures that your core technical documentation, clinical evidence, and quality management system are structured to satisfy multiple jurisdictions efficiently.

4. Optimizes Resource Allocation

Regulatory submissions require significant time, expertise, and financial investment. A clear roadmap helps you allocate resources efficiently, avoiding duplication and focusing effort where it has the greatest impact.

5. Manages Risk

Regulatory risk is business risk. A poorly planned submission can delay market entry, jeopardize partnerships, and consume resources. Strategic planning mitigates these risks.

6. Supports Post-Market Sustainability

Regulatory compliance does not end with approval. A strategic roadmap includes provisions for post-market surveillance, periodic reporting, renewals, and change management, ensuring your product remains compliant throughout its lifecycle.

Our Regulatory Strategy Development Services

1. Device Classification and Regulatory Pathway Assessment

The starting point of any regulatory strategy is accurate classification of your device. Classification determines the level of regulatory scrutiny, the applicable conformity assessment route, and the evidence required.

What We Do:

Classification Analysis: We analyze your device against the classification rules of each target jurisdiction, including EU MDR Annex VIII, FDA classification regulations, SFDA classification rules, TGA classification rules, and other applicable frameworks.

Pathway Determination: Based on classification, we identify the optimal approval pathway. For example:

EU MDR: Class I self-certification, Class Is/Ir with Notified Body involvement for specific aspects, Class IIa/IIb full Notified Body conformity assessment

USA: Premarket Approval (PMA)

KSA: Medical Device Marketing Authorization (MDMA) through SFDA

Brazil: ANVISA registration or notification

China: NMPA filing or registration

Australia: ARTG inclusion through TGA

New Zealand: WAND notification through Medsafe

Classification Strategy: Where classification is ambiguous or where multiple rules could apply, we develop a defensible classification rationale supported by regulatory precedent and guidance.

2. Global Market Prioritization and Sequencing

Not all markets need to be pursued simultaneously. We help you prioritize markets based on commercial objectives, regulatory complexity, and strategic value.

What We Do:

Market Assessment: Evaluate target markets based on device type, competitive landscape, regulatory burden, and commercial potential.

Sequencing Strategy: Determine the optimal order of market entries. For example, achieving CE marking under EU MDR may facilitate approvals in markets that recognize European certification, such as Turkey, Saudi Arabia, and Australia.

Leveraging Approvals: Identify opportunities to use approvals in one jurisdiction to support or accelerate approvals in another, including reference country pathways and abbreviated review procedures.

3. Regulatory Roadmap Development

We develop a detailed, actionable roadmap that maps every step from your current position to market approval in each target jurisdiction.

What We Deliver:

Timeline and Milestones: A clear timeline with key milestones, dependencies, and critical path activities.

Deliverables Checklist: A comprehensive list of documents, evidence, and submissions required for each market.

Resource Requirements: Identification of internal and external resources needed, including testing, clinical evidence, and authorized representation.

Risk Register: Identification of potential regulatory risks and mitigation strategies.

Decision Points: Key decisions that need to be made and the information required to make them.

4. Technical Documentation Strategy

Technical documentation is the foundation of any regulatory submission. We develop a documentation strategy that ensures completeness, consistency, and compliance across all target markets.

What We Do:

Documentation Gap Assessment: Review existing documentation against the requirements of each target market.

Document Architecture: Design a documentation structure that satisfies multiple jurisdictions efficiently, avoiding duplication while meeting specific requirements.

Technical File Preparation Support: Guide the preparation of technical documentation, including device description, specifications, risk management file, verification and validation reports, and labeling.

Clinical Evaluation Strategy: Develop a clinical evaluation strategy that satisfies MDR, FDA, and other regulatory requirements, including literature review, clinical investigation planning, and equivalence assessment.

5. Quality Management System Alignment

Your quality management system must support your regulatory strategy. We ensure that your QMS is aligned with the requirements of each target market.

What We Do:

QMS Gap Assessment: Evaluate your QMS against ISO 13485, FDA QMSR, and other applicable requirements.

QMS Enhancement: Support the development or enhancement of QMS processes to meet regulatory requirements.

Integration with Regulatory Submissions: Ensure that QMS documentation and records support regulatory submissions and audit requirements.

6. Authorized Representation Strategy

Many markets require a local authorized representative. We help you identify and appoint the right representation for each market.

What We Do:

Representative Selection: Identify authorized representatives, sponsors, or agents for each target market.

Panel Access: Provide access to our established panel of EU Reps, CH Reps, UK Reps, and US Agents.

Agreement Support: Assist with the development of representation agreements that clearly define responsibilities and obligations.

7. Submission Preparation and Management

We support the preparation, submission, and management of regulatory applications in all target markets.

What We Do:

Submission Preparation: Prepare or review regulatory submissions, ensuring completeness and compliance.

Regulatory Authority Interactions: Manage communications with regulatory authorities, including responses to questions and requests for additional information.

Submission Tracking: Track submission status and manage timelines to ensure timely approvals.

8. Post-Market Regulatory Strategy

Regulatory obligations continue after approval. We develop post-market strategies that ensure ongoing compliance.

What We Do:

Post-Market Surveillance Planning: Develop PMS plans that satisfy MDR, FDA, and other requirements.

Vigilance and Incident Reporting: Establish procedures for reporting serious incidents and field safety corrective actions.

Periodic Reporting: Support the preparation of Periodic Safety Update Reports (PSURs) and other required reports.

Change Management: Develop procedures for assessing and managing changes to the device, manufacturing process, or supplier base, including regulatory impact assessment.

Renewals and Maintenance: Track certificate and registration renewals to ensure continuous market access.

Our Approach

Phase 1: Discovery and Assessment

We begin by understanding your device, your business objectives, and your target markets. This includes:

Review of device characteristics, intended use, and technology

Assessment of existing documentation and regulatory status

Identification of target markets and commercial priorities

Evaluation of internal capabilities and resource constraints

Phase 2: Strategy Development

Based on the discovery phase, we develop a customized regulatory strategy that includes:

Device classification and regulatory pathway for each market

Market prioritization and sequencing

Detailed regulatory roadmap with timelines and milestones

Documentation and evidence requirements

Resource and budget requirements

Risk assessment and mitigation strategies

Phase 3: Implementation Support

We work alongside your team to implement the strategy, providing:

Hands-on support for documentation preparation

Coordination with testing laboratories, clinical sites, and authorized representatives

Submission preparation and management

Regulatory authority interactions

Ongoing advisory support

Phase 4: Maintenance and Optimization

After approvals are obtained, we support ongoing compliance and identify opportunities to optimize your regulatory position:

Post-market surveillance and reporting

Change management

Renewals and maintenance

Expansion into additional markets

Markets We Support

Our regulatory strategy development services cover all major medical device markets, including:

Why Choose Veritas Quality Solutions

Proven Track Record

We are pioneers in Pakistan for MDR certifications, having successfully guided companies to Class IIa, IIb, and Is certifications with SGS Belgium. We have supported device registrations across KSA, Brazil, UK, Indonesia, Malaysia, China, Australia, New Zealand, Thailand, Azerbaijan, Turkey, Russia, Europe, and USA.

Deep Regulatory Expertise

Our team has extensive experience across the full spectrum of medical device regulations, from the legacy Medical Device Directive (MDD) to the current Medical Device Regulation (MDR), and from ISO 13485 to FDA QMSR.

Global Network

We maintain relationships with Notified Bodies, authorized representatives, testing laboratories, and regulatory consultants around the world, giving you access to the expertise and resources you need.

Practical, Client-Focused Approach

We do not provide generic advice. Every strategy we develop is tailored to your device, your objectives, and your constraints. We work as an extension of your team, providing hands-on support from strategy through to approval.

End-to-End Support

From initial classification through to post-market compliance, we support you at every phase of the regulatory lifecycle.

Frequently Asked Questions

Q: When should I start developing a regulatory strategy?

A: Ideally, regulatory strategy development should begin during the concept or design phase of your device. Early planning allows you to incorporate regulatory requirements into design decisions, avoiding costly changes later. However, we can also develop strategies for devices that are already in development or on the market.

Q: How long does it take to develop a regulatory strategy?

A: The timeline depends on the complexity of your device and the number of target markets. A focused strategy for a single market may take 2–4 weeks, while a comprehensive global strategy may take 6–12 weeks.

Q: Can you help if my device is already approved in one market and I want to expand to others?

A: Yes. We frequently support manufacturers who have existing approvals and want to expand into new markets. We assess your existing documentation and approvals to identify opportunities for leveraging them in new jurisdictions.

Q: Do you provide support for regulatory submissions, or only strategy?

A: We provide both. Our services range from high-level strategy development to hands-on submission preparation and management. You can engage us for strategy only, or for end-to-end support.

Q: How do you stay current with changing regulations?

A: Our team actively monitors regulatory developments through official channels, industry associations, and our network of regulatory professionals. We also participate in industry conferences and training to ensure our knowledge is current.

Get Started

Ready to accelerate your path to market? Contact Veritas Quality Solutions to discuss your regulatory strategy needs. Whether you are developing a new device, expanding into new markets, or seeking to optimize your existing regulatory position, we are here to help.

Veritas Quality Solutions, Your Partner in Quality Assurance